Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

38.5K
The Concept of Multiple Allelism
38.5K
Translation01:31

Translation

159.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
159.0K
Translation01:31

Translation

21.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
21.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

980
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
980
Glucose Transporters01:27

Glucose Transporters

27.9K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.9K
Alternative RNA Splicing02:18

Alternative RNA Splicing

25.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients.

British journal of haematology·2026
Same author

Atrial fibrillation prevalence and its management in aging, transfusion-dependent patients with thalassemia: the FATHAL study.

Blood advances·2026
Same author

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.

American journal of hematology·2025
Same author

Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept.

British journal of haematology·2024
Same author

Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study.

Annals of hematology·2024
Same author

'Phenoconversion' in adult patients with β-thalassemia.

American journal of hematology·2024
Same journal

RNU4ATAC-opathy: Clinical, molecular and transcriptomic insights from a large cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Expanding the clinical spectrum of RNU4ATAC-opathies: more frequent and diverse than assumed.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Delineating the clinical and molecular spectrum of the neurodevelopmental disorder associated with SET.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

KMT2A and KMT2B episignatures address diagnostic challenges associated with rare neurodevelopmental disorders.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Beyond Mistrust: Diverse Biobanking Preferences Among Parents and Adolescents with Sickle Cell Disease.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Correspondence on "Optical mapping in Black genomes: Distinct LCR22 structures and 22q11.2 deletion syndrome mechanisms" by Pastor et al.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

β-Thalassemia.

Raffaella Origa1

  • 1Ospedale Microcitemico "Antonio Cao"-Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|November 5, 2016
PubMed
Summary
This summary is machine-generated.

Beta-thalassemia, a genetic blood disorder, results from reduced or absent beta-globin synthesis. Understanding factors influencing its severity is key to improving patient outcomes and developing new therapies.

More Related Videos

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

Related Experiment Videos

Last Updated: Mar 12, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Beta-thalassemia is a group of inherited blood disorders characterized by reduced or absent synthesis of beta-globin chains.
  • Disease severity ranges from carrier state to transfusion-dependent thalassemia major, primarily driven by alpha-globin chain excess.
  • Ineffective erythropoiesis, caused by precipitated alpha-globin chains, leads to anemia and organ damage.

Purpose of the Study:

  • To review the pathophysiology of beta-thalassemia.
  • To discuss factors influencing disease severity and clinical presentation.
  • To explore current and emerging therapeutic strategies for beta-thalassemia.

Main Methods:

  • Literature review of beta-thalassemia.
  • Analysis of genetic and environmental factors affecting disease expression.
  • Overview of current management and novel therapeutic approaches.

Main Results:

  • Disease severity is linked to alpha-globin chain excess and ineffective erythropoiesis.
  • Factors like co-inherited alpha-thalassemia and increased gamma-globin production can ameliorate disease.
  • Advances in transfusions, iron chelation, and bone marrow transplantation have improved quality of life.

Conclusions:

  • Beta-thalassemia management has evolved, transforming it into a chronic condition.
  • Bone marrow transplantation remains the only cure, while gene therapy and erythropoiesis modulators are under investigation.
  • Further research into genetic modifiers and novel therapies is crucial for improved patient outcomes.